This NADPH oxidase, which is commonly upregulated in human and experimental CAVD in regions with high levels of H2O2 and OPN close to mineralized nuclei [22], is actively involved in CAVD [21]. This evidence concerns the gene FMO5 and congenital bilateral aplasia of vas deferens from CFTR mutation.